How do you take lion's mane?

What strengths and doses did trials use?
TrialDose and schedulePeopleLength
Mori 2009Four 250 mg tablets (96% dry powder) three times a day, against placebo230 men and women aged 50 to 80 with mild cognitive impairment, in two groups of 15216 weeks, then 4 weeks observed after stopping2
Docherty 2023Three 600 mg capsules or placebo every morning after breakfast, 1.8 g a day1Healthy young adults, 43 in the acute analysis, 41 in the chronic128 days1
Li 20203Three 350 mg erinacine A-enriched mycelia capsules a day (5 mg/g erinacine A), with meals, against placebo4Mild Alzheimer's disease449 weeks4
Vigna 2019Three capsules a day, against a control group5; the paper's table lists 400 mg mycelium and 100 mg fruiting body extract per capsule (1200 mg and 300 mg a day)5, while the review gives 1.5 g a day3Seventy-seven people on a low calorie diet: 37 control, 40 Hericium58 weeks5
Grozier 202210 g a day, as 5 g in each of two muffins, morning and night, against placebo muffins624 college-age adults (Hericium: 4 males, 8 females; placebo: 6 males, 6 females)64 weeks6
SurendranOne drink of 3 g extract in 250 mL, against a control drink718 healthy adults aged 18 to 35 years7Single dose, crossover with a seven-day washout7
Nagano 2010Hericium cookies or placebo cookies; the review gives 4 a day, 2.0 g powder a day83Thirty females84 weeks8

Trials gave lion's mane by mouth: in the Docherty 2023 trial of healthy young adults (43 in the acute analysis, 41 in the chronic), it was three 600 mg capsules or placebo every morning after breakfast for 28 days (1.8 g a day).1

What strengths and doses did trials use?

The table is set at the top of the page

Maker strengths for shop capsules could not be checked, because the product pages refused the request.

Is there a label or regulator dose?

A DailyMed search for "lion's mane" and "Hericium" returned no labels, and no EFSA or Health Canada page turned up. The one regulator text saved is the FDA letter on GRAS notice GRN 001124, which concerned β-glucans from Hericium erinaceus strain BCRC 35669 at up to 150 mg per serving in foods; FDA ceased its evaluation at the notifier's request, a request FDA says it had recommended.9

How is lion's mane taken and prepared?

Saved trial descriptions give oral capsules, tablets, cookies, muffins and a drink, and no labelled route turned up. Timing ran from once every morning after breakfast in the Docherty 2023 trial to three times a day in the Mori 2009 trial.12 In the Surendran trial the extract was drunk within 15 min in 30 mL of lemon squash and 220 mL of water, after a croissant and water breakfast and a baseline test session.7

No maker's mixing instruction turned up, and no saved source gives a teaspoon measure or a concentration in mg/mL.

Is there a cycle or a stepped dose?

No trial or label found states dose stepping or a cycle. In the Mori 2009 trial, scores on a cognitive function scale rose with the duration of intake and fell significantly at week 4 after the 16 weeks of intake ended.2

What side effects were reported?

The Li 2020 trial reports four dropouts for abdominal discomfort, nausea and skin rash and no other adverse events.43 A systematic review says potential side effects, commonly unreported, include stomach discomfort, headache and allergic reactions.3 For the Mori 2009 trial, its PubMed entry says laboratory tests showed no adverse effect of Yamabushitake, while the review lists mild stomach discomfort and diarrhea in 7 on Yamabushitake against 6 on placebo, with no treatment needed.23

Frequently asked questions

What do sources say about storing lion's mane?

A search of DailyMed, PubMed, the registry and the web returned no storage conditions, before or after opening or mixing.

What is not known about lion's mane dosing?

No dose-finding human result turned up. A Northumbria University dose trial in healthy adults (NCT07759687, not yet recruiting) lists 20:1 fruiting body extract arms of 50 mg, 100 mg, 150 mg and 1.5 g against placebo capsules, and has no saved results.10

References

  1. PMC. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. 2023. pmc.ncbi.nlm.nih.gov
  2. PubMed. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. 2009. pubmed.ncbi.nlm.nih.gov
  3. PMC. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. 2025. pmc.ncbi.nlm.nih.gov
  4. PMC. Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. 2020. pmc.ncbi.nlm.nih.gov
  5. PMC. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?. 2019. pmc.ncbi.nlm.nih.gov
  6. PMC. Four Weeks of Hericium erinaceus Supplementation Does Not Impact Markers of Metabolic Flexibility or Cognition. pmc.ncbi.nlm.nih.gov
  7. PMC. Acute effects of a standardised extract of Hericium erinaceus (Lion’s Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. 2025. pmc.ncbi.nlm.nih.gov
  8. PubMed. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. 2010. pubmed.ncbi.nlm.nih.gov
  9. FDA. GRAS Notice (GRN) 1124 Agency Response Letter. fda.gov
  10. ClinicalTrials.gov. NCT07759687: Lion's Mane Dosing on Attention and Mood. 2026. clinicaltrials.gov